Since Aꞵ starts to accumulate before tau in the preclinical stage of AD (Sperling et al., 2011), it is often difficult to disentangle the phenomena that are solely and specifically attributed to tau pathology. The gene discussed is MAPT; the disease is Alzheimer disease.